Symbols / HTFL Stock $29.39 -0.41% Heartflow, Inc.

Healthcare • Health Information Services • United States • NMS
HTFL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. John C.M. Farquhar
Exch · Country NMS · United States
Market Cap 2.53B
Enterprise Value 2.38B
Income -116.79M
Sales 176.03M
FCF (ttm) -30.88M
Book/sh 3.52
Cash/sh 2.06
Employees 843
Insider 10d —
IPO Aug 11, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -101.87
PEG —
P/S 14.40
P/B 8.34
P/C —
EV/EBITDA -37.94
EV/Sales 13.50
Quick Ratio 4.87
Current Ratio 5.20
Debt/Eq 7.34
LT Debt/Eq —
EPS (ttm) -3.17
EPS next Y -0.29
EPS Growth —
Revenue Growth 40.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-14
Earnings (prior) 2026-03-18
ROA -16.75%
ROE -111.37%
ROIC —
Gross Margin 76.80%
Oper. Margin -36.13%
Profit Margin -66.35%
Shs Outstand 86.24M
Shs Float 65.93M
Insider Own 5.20%
Instit Own 70.75%
Short Float 6.54%
Short Ratio 3.36
Short Interest 5.55M
52W High 41.22
vs 52W High -28.70%
52W Low 20.13
vs 52W Low 46.00%
Beta —
Impl. Vol. 1.81%
Rel Volume 0.59
Avg Volume 1.38M
Volume 818.04K
Target (mean) $37.67
Tgt Median $36.50
Tgt Low $35.00
Tgt High $43.00
# Analysts 6
Recom Buy
Prev Close $29.51
Price $29.39
Change -0.41%
About

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in Mountain View, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$37.67
Mean price target
2. Current target
$29.39
Latest analyst target
3. DCF / Fair value
$-6.45
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$29.39
Low
$35.00
High
$43.00
Mean
$37.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-04 init William Blair — → Outperform —
2026-03-19 main JP Morgan Overweight → Overweight $35
2026-03-19 main Canaccord Genuity Buy → Buy $43
2026-03-19 main Wells Fargo Overweight → Overweight $35
2026-03-09 main Canaccord Genuity Buy → Buy $40
2026-01-28 init Wells Fargo — → Overweight $38
2025-11-13 main Canaccord Genuity Buy → Buy $40
2025-11-13 main JP Morgan Overweight → Overweight $40
2025-11-13 main Stifel Buy → Buy $40
2025-09-22 main Canaccord Genuity Buy → Buy $39
2025-09-02 init Stifel — → Buy $35
2025-09-02 init Canaccord Genuity — → Buy $35
2025-09-02 init Piper Sandler — → Overweight $38
2025-09-02 init JP Morgan — → Overweight $36
News
RSS: Latest HTFL news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-30 BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 2,000,000 $29.18 $58,898,336
2026-04-10 FARQUHAR JOHN C. M. Chief Executive Officer — 22,562 $26.72 $602,857
2026-04-01 ROGERS CAMPBELL D M.D. Officer — 64,533 $24.64 $1,590,093
2026-04-01 ROGERS CAMPBELL D M.D. Officer — 67,017 $2.22 $150,556
2026-03-19 ROGERS CAMPBELL D M.D. Officer — 64,533 $25.69 $1,658,033
2026-03-19 ROGERS CAMPBELL D M.D. Officer — 67,017 $2.22 $148,778
2026-03-18 FARQUHAR JOHN C. M. Chief Executive Officer — 9,725 $25.00 $243,125
2026-03-11 BARABE TIMOTHY CRAIG Director — 8,667 $2.22 $19,241
2026-03-10 FARQUHAR JOHN C. M. Chief Executive Officer — 12,837 $22.66 $290,886
2026-03-06 FARQUHAR JOHN C. M. Chief Executive Officer — 2,631 $22.98 $60,460
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
176.03
+39.92%
125.81
+44.32%
87.17
Operating Revenue
176.03
+39.92%
125.81
+44.32%
87.17
Cost Of Revenue
40.84
+30.22%
31.36
+7.68%
29.12
Reconciled Cost Of Revenue
40.84
+30.22%
31.36
+7.68%
29.12
Gross Profit
135.20
+43.14%
94.45
+62.70%
58.05
Operating Expense
199.26
+28.00%
155.67
+18.86%
130.97
Research And Development
64.92
+49.18%
43.52
+21.37%
35.85
Selling General And Administration
134.34
+19.79%
112.15
+17.92%
95.11
Total Expenses
240.10
+28.38%
187.03
+16.83%
160.09
Operating Income
-64.07
-4.65%
-61.22
+16.04%
-72.91
Total Operating Income As Reported
-64.07
-4.65%
-61.22
+16.04%
-72.91
EBITDA
-93.12
-42.14%
-65.51
-4.35%
-62.78
Normalized EBITDA
-50.18
-2.62%
-48.90
+24.33%
-64.62
Reconciled Depreciation
8.57
+5.93%
8.09
+6.03%
7.63
EBIT
-101.69
-38.16%
-73.61
-4.53%
-70.41
Total Unusual Items
-42.94
-158.43%
-16.62
-1004.08%
1.84
Total Unusual Items Excluding Goodwill
-42.94
-158.43%
-16.62
-1004.08%
1.84
Special Income Charges
-6.36
0.00
0.00
Other Special Charges
6.36
—
—
Net Income
-116.79
-21.12%
-96.43
-0.81%
-95.66
Pretax Income
-116.87
-21.27%
-96.37
-1.33%
-95.11
Net Non Operating Interest Income Expense
-9.63
+48.48%
-18.70
+2.78%
-19.24
Interest Expense Non Operating
15.17
-33.36%
22.77
-7.80%
24.69
Net Interest Income
-9.63
+48.48%
-18.70
+2.78%
-19.24
Interest Expense
15.17
-33.36%
22.77
-7.80%
24.69
Interest Income Non Operating
5.54
+36.20%
4.07
-25.49%
5.46
Interest Income
5.54
+36.20%
4.07
-25.49%
5.46
Other Income Expense
-43.17
-162.42%
-16.45
-456.27%
-2.96
Other Non Operating Income Expenses
-0.22
-232.74%
0.17
+103.50%
-4.79
Gain On Sale Of Security
-36.58
-120.15%
-16.62
-1004.08%
1.84
Tax Provision
-0.08
-243.40%
0.05
-90.31%
0.55
Tax Rate For Calcs
0.00
-99.52%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.04
+98.77%
-3.49
-1004.08%
0.39
Net Income Including Noncontrolling Interests
-116.79
-21.12%
-96.43
-0.81%
-95.66
Net Income From Continuing Operation Net Minority Interest
-116.79
-21.12%
-96.43
-0.81%
-95.66
Net Income From Continuing And Discontinued Operation
-116.79
-21.12%
-96.43
-0.81%
-95.66
Net Income Continuous Operations
-116.79
-21.12%
-96.43
-0.81%
-95.66
Normalized Income
-73.89
+11.29%
-83.30
+14.22%
-97.11
Net Income Common Stockholders
-116.79
-21.12%
-96.43
+22.04%
-123.69
Diluted EPS
—
-1.20
+38.24%
-1.94
Basic EPS
—
-1.20
+38.24%
-1.94
Basic Average Shares
—
80.62
+26.24%
63.86
Diluted Average Shares
—
80.62
+26.24%
63.86
Diluted NI Availto Com Stockholders
-116.79
-21.12%
-96.43
+22.04%
-123.69
Preferred Stock Dividends
—
—
28.03
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
359.45
+202.81%
118.70
-35.85%
185.05
Current Assets
220.20
+167.60%
82.29
-44.57%
148.45
Cash Cash Equivalents And Short Term Investments
176.79
+244.16%
51.37
-58.16%
122.77
Cash And Cash Equivalents
44.78
-12.83%
51.37
-58.16%
122.77
Other Short Term Investments
132.01
0.00
—
Receivables
29.34
+19.09%
24.64
+19.92%
20.55
Accounts Receivable
29.34
+19.09%
24.64
+19.92%
20.55
Gross Accounts Receivable
29.97
+17.74%
25.45
+17.82%
21.60
Allowance For Doubtful Accounts Receivable
-0.63
+23.10%
-0.81
+23.06%
-1.06
Other Receivables
—
2.45
+25.60%
1.95
Prepaid Assets
5.96
+97.68%
3.02
+16.80%
2.58
Current Deferred Assets
6.67
+171.87%
2.45
+25.60%
1.95
Restricted Cash
0.00
-100.00%
0.15
0.00
Other Current Assets
1.44
+117.82%
0.66
+10.70%
0.60
Total Non Current Assets
139.25
+282.38%
36.42
-0.51%
36.60
Net PPE
26.07
-5.95%
27.73
-10.22%
30.88
Gross PPE
38.58
-51.30%
79.22
-2.86%
81.55
Accumulated Depreciation
-12.51
+75.71%
-51.49
-1.63%
-50.66
Properties
0.00
0.00
0.00
Buildings And Improvements
17.49
-7.00%
18.80
-10.29%
20.96
Machinery Furniture Equipment
18.87
-67.66%
58.33
-0.25%
58.47
Construction In Progress
0.14
+418.52%
0.03
-52.63%
0.06
Leases
2.09
+1.41%
2.06
+0.00%
2.06
Goodwill And Other Intangible Assets
—
-44.84
-10.48%
-40.59
Other Intangible Assets
—
-44.84
-10.48%
-40.59
Investments And Advances
103.36
0.00
—
Non Current Accounts Receivable
—
3.70
+274.60%
0.99
Non Current Deferred Assets
4.26
+3.55%
4.11
+316.40%
0.99
Other Non Current Assets
5.55
+21.21%
4.58
-3.32%
4.73
Total Liabilities Net Minority Interest
58.80
-93.99%
978.19
+1.62%
962.62
Current Liabilities
42.37
+26.08%
33.60
+2.41%
32.81
Payables And Accrued Expenses
33.90
+37.23%
24.70
+11.99%
22.05
Payables
3.17
+10.42%
2.87
-0.59%
2.89
Accounts Payable
3.17
+10.42%
2.87
-0.59%
2.89
Current Accrued Expenses
30.73
+40.76%
21.83
+13.88%
19.17
Pensionand Other Post Retirement Benefit Plans Current
—
18.21
+19.56%
15.23
Current Debt And Capital Lease Obligation
5.92
+9.34%
5.42
+5.41%
5.14
Current Capital Lease Obligation
5.92
+9.34%
5.42
+5.41%
5.14
Current Deferred Liabilities
0.63
-39.77%
1.04
-50.64%
2.11
Current Deferred Revenue
0.63
-39.77%
1.04
-50.64%
2.11
Other Current Liabilities
1.93
-21.36%
2.45
-30.29%
3.51
Total Non Current Liabilities Net Minority Interest
16.43
-98.26%
944.58
+1.59%
929.80
Long Term Debt And Capital Lease Obligation
16.13
-89.59%
154.97
-0.32%
155.46
Long Term Debt
—
136.43
+1.81%
134.01
Long Term Capital Lease Obligation
16.13
-12.97%
18.54
-13.60%
21.45
Other Non Current Liabilities
0.30
+41.59%
0.21
-50.12%
0.43
Preferred Securities Outside Stock Equity
0.00
-100.00%
768.57
+0.00%
768.57
Stockholders Equity
300.65
+134.98%
-859.48
-10.54%
-777.56
Common Stock Equity
300.65
+134.98%
-859.48
-10.54%
-777.56
Capital Stock
0.09
+1316.67%
0.01
+20.00%
0.01
Common Stock
0.09
+1316.67%
0.01
+20.00%
0.01
Preferred Stock
0.00
0.00
—
Share Issued
85.28
+5.79%
80.62
+0.00%
80.62
Ordinary Shares Number
85.28
+5.79%
80.62
+0.00%
80.62
Additional Paid In Capital
1,388.74
+1137.28%
112.24
+15.16%
97.47
Retained Earnings
-1,087.75
-12.03%
-970.96
-11.03%
-874.53
Gains Losses Not Affecting Retained Earnings
-0.42
+44.95%
-0.77
-54.09%
-0.50
Other Equity Adjustments
-0.42
+44.95%
-0.77
-54.09%
-0.50
Total Equity Gross Minority Interest
300.65
+134.98%
-859.48
-10.54%
-777.56
Total Capitalization
300.65
+141.58%
-723.05
-12.35%
-643.56
Working Capital
177.83
+265.29%
48.68
-57.90%
115.63
Invested Capital
300.65
+141.58%
-723.05
-12.35%
-643.56
Total Debt
22.05
-86.25%
160.38
-0.13%
160.60
Net Debt
—
85.06
+656.73%
11.24
Capital Lease Obligations
22.05
-7.93%
23.95
-9.92%
26.59
Net Tangible Assets
300.65
+134.98%
-859.48
-10.54%
-777.56
Tangible Book Value
300.65
+134.98%
-859.48
-10.54%
-777.56
Available For Sale Securities
103.36
—
—
Derivative Product Liabilities
0.00
-100.00%
20.84
+289.95%
5.34
Investmentin Financial Assets
103.36
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-54.02
+21.71%
-69.00
+9.72%
-76.43
Cash Flow From Continuing Operating Activities
-54.02
+21.71%
-69.00
+9.72%
-76.43
Net Income From Continuing Operations
-116.79
-21.12%
-96.43
-0.81%
-95.66
Depreciation Amortization Depletion
8.57
+5.93%
8.09
+6.03%
7.63
Depreciation
8.57
+5.93%
8.09
+6.03%
7.63
Amortization Cash Flow
—
3.70
+15.63%
3.20
Depreciation And Amortization
8.57
+5.93%
8.09
+6.03%
7.63
Amortization Of Intangibles
—
3.70
+15.63%
3.20
Other Non Cash Items
6.44
+77.60%
3.62
-59.30%
8.91
Stock Based Compensation
13.96
+36.74%
10.21
-13.99%
11.87
Provisionand Write Offof Assets
0.19
+177.05%
-0.24
-120.50%
1.19
Operating Gains Losses
42.94
+158.43%
16.62
+1004.08%
-1.84
Gain Loss On Investment Securities
36.58
+120.15%
16.62
+1004.08%
-1.84
Unrealized Gain Loss On Investment Securities
—
0.00
-100.00%
5.12
Change In Working Capital
-7.66
+29.56%
-10.88
-27.33%
-8.54
Change In Receivables
-4.89
-27.10%
-3.85
+58.83%
-9.35
Changes In Account Receivables
-4.89
-27.10%
-3.85
+58.83%
-9.35
Change In Prepaid Assets
-7.94
-695.89%
-1.00
-179.55%
-0.36
Change In Payables And Accrued Expense
9.53
+9527.27%
0.10
-96.84%
3.14
Change In Accrued Expense
9.31
+2086.15%
0.43
-88.67%
3.76
Change In Payable
0.22
+166.67%
-0.33
+47.51%
-0.62
Change In Account Payable
0.22
+166.67%
-0.33
+47.51%
-0.62
Change In Other Current Assets
-0.73
+72.83%
-2.70
-571.14%
-0.40
Change In Other Current Liabilities
-3.63
-5.62%
-3.43
-118.52%
-1.57
Investing Cash Flow
-238.57
-5375.51%
-4.36
+28.63%
-6.11
Cash Flow From Continuing Investing Activities
-238.57
-5375.51%
-4.36
+28.63%
-6.11
Net PPE Purchase And Sale
-5.03
-15.33%
-4.36
+28.63%
-6.11
Purchase Of PPE
-5.03
-15.33%
-4.36
+28.63%
-6.11
Capital Expenditure
-5.03
-15.33%
-4.36
+28.63%
-6.11
Net Investment Purchase And Sale
-233.54
0.00
0.00
Purchase Of Investment
-233.54
0.00
0.00
Financing Cash Flow
286.04
+12686.90%
2.24
-98.68%
169.32
Cash Flow From Continuing Financing Activities
286.04
+12686.90%
2.24
-98.68%
169.32
Net Issuance Payments Of Debt
-42.37
0.00
0.00
Issuance Of Debt
72.77
0.00
0.00
Repayment Of Debt
-115.14
0.00
0.00
Long Term Debt Issuance
72.77
0.00
0.00
Long Term Debt Payments
-115.14
0.00
0.00
Net Long Term Debt Issuance
-42.37
0.00
0.00
Net Common Stock Issuance
332.39
0.00
+100.00%
-0.23
Common Stock Payments
0.00
0.00
+100.00%
-0.23
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-0.23
Proceeds From Stock Option Exercised
3.30
-27.74%
4.56
+674.87%
0.59
Net Other Financing Charges
-7.27
-212.59%
-2.33
—
Changes In Cash
-6.55
+90.79%
-71.12
-181.96%
86.78
Effect Of Exchange Rate Changes
0.19
+170.48%
-0.27
+46.23%
-0.50
Beginning Cash Position
55.84
-56.11%
127.23
+210.64%
40.96
End Cash Position
49.48
-11.38%
55.84
-56.11%
127.23
Free Cash Flow
-59.05
+19.51%
-73.36
+11.12%
-82.54
Interest Paid Supplemental Data
8.57
-55.26%
19.16
-7.87%
20.80
Income Tax Paid Supplemental Data
—
—
0.41
Amortization Of Securities
-1.68
0.00
0.00
Common Stock Issuance
332.39
0.00
0.00
Issuance Of Capital Stock
332.39
0.00
-100.00%
168.96
Net Preferred Stock Issuance
0.00
0.00
-100.00%
168.96
Preferred Stock Issuance
0.00
0.00
-100.00%
168.96
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category